<?xml version="1.0"?>
  <rss version="2.0">
    <channel>
      <title>Melphalan News : GoldBamboo.com</title>
      <link>http://goldbamboo.com/</link>
      <description>Melphalan News from GoldBamboo.com</description>
      <language>en-us</language>
      <copyright>&amp;copy; 2005, Gold Bamboo LLC, All Rights Reserved</copyright>
      
	<item>
        <title>Delcath Systems Reports Positive Data From Ongoing Phase II Multi-Histology Trial At The Second International Symposium On Regional Cancer Therapies</title>
        <link>http://goldbamboo.com/news-a222847.html</link>
        <description>Delcath Systems, Inc. (Nasdaq: DCTH) today reported encouraging interim results from its ongoing Phase II multi-histology trial of the treatment of unresectable primary and metastatic cancers of the liver using the Delcath system with melphalan. [click link for full article]</description>
		 <pubDate>Tue, 27 Feb 2007 08:00 EST</pubDate>
	</item>
	<item>
        <title>VELCADE(R) (Bortezomib) For Injection Showed Unprecedented Results In Newly Diagnosed Multiple Myeloma Patients</title>
        <link>http://goldbamboo.com/news-a186067.html</link>
        <description>MillenniumPharmaceuticals, Inc. (Nasdaq: MLNM) today announced results of a studythat showed VELCADE in combination with melphalan and prednisone (V-MP)appeared significantly superior to melphalan and prednisone (MP) alone intreating elderly patients with newly diagnosed multiple myeloma (MM) whowere ineligible for stem cell transplantation. [click link for full article]</description>
		 <pubDate>Thu, 22 Jun 2006 06:00 EST</pubDate>
	</item>
	

    </channel>
  </rss>
